
NASDAQHealthcareMedical - Instruments & Supplies
أحدث البيانات المتاحة
157.18 US$
+1.15 US$ · +0.74%
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
الإغلاق السابق
157.18 US$
+1.15 US$ · +0.74%
بعد ساعات التداول
157.18 US$
0.00 US$ · 0.00%
8 أكتوبر، 7:30 م ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
نطاق اليوم
السعر الحالي 157.18 US$
نطاق 52 أسبوعًا
السعر الحالي 157.18 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
58
قيمة عادلة
المشاعر
68
صعودي
المخاطر
30
مخاطر متوسطة
الزخم
60
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
نطاق اليوم
السعر الحالي 157.18 US$
نطاق 52 أسبوعًا
السعر الحالي 157.18 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 2.23 مليار USD | 2.38 مليار USD | 2.26 مليار USD | 2.28 مليار USD | 1.32 مليار USD |
| تكلفة البضاعة المباعة | 1.41 مليار USD | 1.56 مليار USD | 1.52 مليار USD | 1.58 مليار USD | 824.82 مليون USD |
| الربح الإجمالي | 819.66 مليون USD | 824.78 مليون USD | 739.87 مليون USD | 697.76 مليون USD | 491.49 مليون USD |
| البحث والتطوير | 87.5 مليون USD | 88.62 مليون USD | 85.34 مليون USD | 92.98 مليون USD | 47.5 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 625.21 مليون USD | 638.76 مليون USD | 606.69 مليون USD | 608.35 مليون USD | 302.58 مليون USD |
| نفقات التشغيل | 712.71 مليون USD | 781.82 مليون USD | 717.05 مليون USD | 740.66 مليون USD | 368.25 مليون USD |
| دخل الفوائد | 10.31 مليون USD | 10.79 مليون USD | 7.51 مليون USD | 4.43 مليون USD | 2.84 مليون USD |
| مصاريف الفوائد | 105.38 مليون USD | 106.54 مليون USD | 102.73 مليون USD | 70.81 مليون USD | 858 ألف USD |
| الاستهلاك والإطفاء | 200.74 مليون USD | 219.51 مليون USD | 228.77 مليون USD | 235.15 مليون USD | 89.7 مليون USD |
| الدخل التشغيلي | 106.95 مليون USD | 42.96 مليون USD | 22.83 مليون USD | −42.9 مليون USD | 123.25 مليون USD |
| صافي الدخل | 732 ألف USD | −117.69 مليون USD | −29.66 مليون USD | −74.29 مليون USD | 103.14 مليون USD |
تم تحديث حقائق الشركة 9 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
186.4 US$
ارتفاع محتمل بنسبة 18.59%| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 18 مارس 2002 | 3:2 | — | — |
تقسيم الأسهم | 1 أبريل 1993 | 3:2 | — | — |
ساري 18 مارس 2002
3:2
ساري 1 أبريل 1993
3:2
صناديق متداولة تفصح عن تعرضها لهذا السهم.
iShares Core S&P Small-Cap ETFIJR233.23 مليون0.23%102.88 مليار USD0.06%137.31 US$+0.17%
Vanguard Morningstar Total Stock Market ETFVTI137.34 مليون0.01%2.3 ترليون USD0.03%379.56 US$-0.39%
iShares Russell 2000 ETFIWM101.45 مليون0.13%77.7 مليار USD0.19%277.57 US$-0.05%
Vanguard Morningstar Small-Cap ETFVB99.52 مليون0.05%185.3 مليار USD0.03%287.63 US$+0.23%
Vanguard Morningstar Small-Cap Value ETFVBR63.16 مليون0.09%68.2 مليار USD0.05%233.91 US$+0.75%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV54.36 مليون0.20%26.69 مليار USD0.33%38.10 US$+0.82%
Vanguard Extended Market ETFVXF50.25 مليون0.05%95.4 مليار USD0.05%233.13 US$-0.15%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM36.42 مليون0.23%15.8 مليار USD0.03%53.36 US$+0.15%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.